Az acetilszalicilsav-rezisztencia klinikai jelentosége cerebrovascularis betegek esetében

Andrea Fehér, Gabriella Pusch, Gábor Harang, B. Gasztonyi, E. Papp, Dóra Werling, Marianna Menyhárt, Hedvig Komáromy, L. Szapáry, G. Fehér

Research output: Article

Abstract

INTRODUCTION: In the past few years, a number of studies have been published about acetylsalicylic acid resistance and its potential clinical consequences. PATIENTS AND METHODS: 281 patients with chronic cerebrovascular disease have been involved in our study. The patients were divided in two groups on the basis of their optical aggregometer results (acetylsalicylic acid responder vs. resistant). We compared the risk profiles, drug therapies, laboratory parameters and clinical outcomes of the two groups. RESULTS: Acetylsalicylic acid resistant patients were more likely to be women [23 (45.1%) vs. 92 (40%) (p

Original languageHungarian
Pages (from-to)719-724
Number of pages6
JournalLege Artis Medicinae
Volume21
Issue number11
Publication statusPublished - nov. 2011

Fingerprint

Cerebrovascular Disorders
Aspirin
Chronic Disease
Drug Therapy

Keywords

  • Aspirin
  • Optical aggregometry
  • Resistance
  • Secondary prevention
  • Stroke
  • TIA

ASJC Scopus subject areas

  • Medicine(all)

Cite this

Az acetilszalicilsav-rezisztencia klinikai jelentosége cerebrovascularis betegek esetében. / Fehér, Andrea; Pusch, Gabriella; Harang, Gábor; Gasztonyi, B.; Papp, E.; Werling, Dóra; Menyhárt, Marianna; Komáromy, Hedvig; Szapáry, L.; Fehér, G.

In: Lege Artis Medicinae, Vol. 21, No. 11, 11.2011, p. 719-724.

Research output: Article

Fehér, A, Pusch, G, Harang, G, Gasztonyi, B, Papp, E, Werling, D, Menyhárt, M, Komáromy, H, Szapáry, L & Fehér, G 2011, 'Az acetilszalicilsav-rezisztencia klinikai jelentosége cerebrovascularis betegek esetében', Lege Artis Medicinae, vol. 21, no. 11, pp. 719-724.
Fehér, Andrea ; Pusch, Gabriella ; Harang, Gábor ; Gasztonyi, B. ; Papp, E. ; Werling, Dóra ; Menyhárt, Marianna ; Komáromy, Hedvig ; Szapáry, L. ; Fehér, G. / Az acetilszalicilsav-rezisztencia klinikai jelentosége cerebrovascularis betegek esetében. In: Lege Artis Medicinae. 2011 ; Vol. 21, No. 11. pp. 719-724.
@article{e1391d8b8b754554874ea3237b13d541,
title = "Az acetilszalicilsav-rezisztencia klinikai jelentos{\'e}ge cerebrovascularis betegek eset{\'e}ben",
abstract = "INTRODUCTION: In the past few years, a number of studies have been published about acetylsalicylic acid resistance and its potential clinical consequences. PATIENTS AND METHODS: 281 patients with chronic cerebrovascular disease have been involved in our study. The patients were divided in two groups on the basis of their optical aggregometer results (acetylsalicylic acid responder vs. resistant). We compared the risk profiles, drug therapies, laboratory parameters and clinical outcomes of the two groups. RESULTS: Acetylsalicylic acid resistant patients were more likely to be women [23 (45.1{\%}) vs. 92 (40{\%}) (p",
keywords = "Aspirin, Optical aggregometry, Resistance, Secondary prevention, Stroke, TIA",
author = "Andrea Feh{\'e}r and Gabriella Pusch and G{\'a}bor Harang and B. Gasztonyi and E. Papp and D{\'o}ra Werling and Marianna Menyh{\'a}rt and Hedvig Kom{\'a}romy and L. Szap{\'a}ry and G. Feh{\'e}r",
year = "2011",
month = "11",
language = "Hungarian",
volume = "21",
pages = "719--724",
journal = "Lege Artis Medicinae",
issn = "0866-4811",
publisher = "Literatura Medica Publishing House",
number = "11",

}

TY - JOUR

T1 - Az acetilszalicilsav-rezisztencia klinikai jelentosége cerebrovascularis betegek esetében

AU - Fehér, Andrea

AU - Pusch, Gabriella

AU - Harang, Gábor

AU - Gasztonyi, B.

AU - Papp, E.

AU - Werling, Dóra

AU - Menyhárt, Marianna

AU - Komáromy, Hedvig

AU - Szapáry, L.

AU - Fehér, G.

PY - 2011/11

Y1 - 2011/11

N2 - INTRODUCTION: In the past few years, a number of studies have been published about acetylsalicylic acid resistance and its potential clinical consequences. PATIENTS AND METHODS: 281 patients with chronic cerebrovascular disease have been involved in our study. The patients were divided in two groups on the basis of their optical aggregometer results (acetylsalicylic acid responder vs. resistant). We compared the risk profiles, drug therapies, laboratory parameters and clinical outcomes of the two groups. RESULTS: Acetylsalicylic acid resistant patients were more likely to be women [23 (45.1%) vs. 92 (40%) (p

AB - INTRODUCTION: In the past few years, a number of studies have been published about acetylsalicylic acid resistance and its potential clinical consequences. PATIENTS AND METHODS: 281 patients with chronic cerebrovascular disease have been involved in our study. The patients were divided in two groups on the basis of their optical aggregometer results (acetylsalicylic acid responder vs. resistant). We compared the risk profiles, drug therapies, laboratory parameters and clinical outcomes of the two groups. RESULTS: Acetylsalicylic acid resistant patients were more likely to be women [23 (45.1%) vs. 92 (40%) (p

KW - Aspirin

KW - Optical aggregometry

KW - Resistance

KW - Secondary prevention

KW - Stroke

KW - TIA

UR - http://www.scopus.com/inward/record.url?scp=83455177592&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=83455177592&partnerID=8YFLogxK

M3 - Article

AN - SCOPUS:83455177592

VL - 21

SP - 719

EP - 724

JO - Lege Artis Medicinae

JF - Lege Artis Medicinae

SN - 0866-4811

IS - 11

ER -